In summary, we identified 338 new targets of SCFFbxo7 using a high-throughput, cell-independent proteomic approach and validated Gsk3β and Tomm20 as new substrates, and argue against defective regulation of Tomm20 by Fbxo7 as an underlying mechanism in PD. The gene discussed is GSK3B; the disease is Parkinson disease.